Saturday afternoon Q & A (2017 Conference) (LDN, low dose naltrexone)

Drug relieves chronic pain without the addiction risk

Futurity
17 February 2021
https://www.futurity.org/naltrexone-chronic-pain-addiction-opioids-2519…

A low dose of a drug called naltrexone is a good option for patients with orofacial and chronic pain, without the risk of addiction, researchers report.

Low-Dose Naltrexone Co-Treatment in the Prevention of Opioid-Induced Hyperalgesia (Abstract)

Cureus
02 September 2021
https://pubmed.ncbi.nlm.nih.gov/34646707/

LDN in Clinical Practice - Andrew McCall, MB, ChB, DFM (2021 Conference) (LDN, low dose naltrexone)

Use of LDN for Chronic Pain - Sahar Swidan, PHARM.D., ABAAHP, FAARFM, FACA (2021 Conference) (LDN, low dose naltrexone)

This talk is on the use of LDN for chronic pain. She reviews LDN’s actions in the CNS and the PNS, the immunomodulating effect of LDN, and some clinical trials on the use of LDN.

Ulcerative Colitis - Pamela Smith, MD, MS (2021 Conference) (LDN, low dose naltrexone)

PTSD and other mental health treatment with opioid antagonist... - Galyn Forster, MS, LPC (2021 Conference) (LDN, low dose naltrexone)

New approaches to managing fibromyalgia pain - Ginevra Liptan, MD (2021 Conference) (LDN, low dose naltrexone)

Endogenous opioids modulate inflammation in the animal model of Multiple Sclerosis - Chirag Patel, MD (2021 Conference) (LDN, low dose naltrexone)